Week 259 Review - Great week but Optibiotix spoils the party

This could have been a fantastic week, even if OPTI:Optibiotix had just stayed still. However, despite a recent trading statement that was frankly amazing, the share price is still drifting. A 2p drop this week cost over £2,200 so it shows how well everything else did when the overall losses were only £601. The deficit between cost and value widened to £35,097 and overall potfolio value is £83,714.

Only one share had a significant percentage loss this week, with WRES:W Resources dropping 9% as it became clear production levels are so low that they are not making ends meet. Glad I only trusted a small amount to this donkey.

CAML:Central Asia Metals climbed 5% and is making steady progress as the price of copper increases, despite having suspended the dividend. My SIPP holding is only 10% down now.

N4P:N4 Pharma also increased 5% but I don't know why. I still hold out very little hope of these remaining solvent.

TLOU:Tlou Energy technically stayed the same price, but I succeeded in getting my entire application of 8,809 open offer shares at 2.2p costing £193.80 with no commission. As that's the current bid price, it meant a 5% improvement on bid price compared to average purchase price. I now have 40,000 shares so just have to wait for the power purchase agreement and financing to be finalised and I'm convinced this will be a great investment.

APAX:Apax Global Alpha is one of my new magic formula shares and climbed an impressive 8% this week after a portfolio update. They are now 4% up and in profit by £36.

Share of the week is JLP:Jubilee Metals, climbing a whopping 21% and going £372 into profit. I was so excited about prospects that I spent my ISA SBTX:SkinBioTherapeutics cash on another 37,604 shares at 3.997p costing £1,514.98. Given the price ended the week at 4.6p, these have already made a decent profit. We're only just back around pre-covid prices and metal prices have risen significantly, so I'm now of a mind to hold these for much longer than I originally anticipated, Not sure how I'm going to get back into SBTX though...

Cost isn't quite back to where it was before recent sales so I still have some ammo. Value actually dipped slightly.

Despite the slight drop we're still above the trend line, but dropping at the same rate.

The ISA and share accounts look like this

			Weekly Change
Cash	£14.48		-£1,708.78
Portfolio cost	£62,366.49		+£1,708.78
Portfolio sell value (bid price-commission)	£42,401.64	(-33.1%)	-£997.14
Potential profits	£372.89		+£372.89
Yr 5 Dividends	£0.85		+£0
Yr 5 Profit from sales	£35.20		+£0
Yr 5 Average monthly cash profit	-£0.44	(-0%)	+£0.01
Total Dividends	£1,343.15		+£0
Total Profit from sales	£20,426.61		+£0
Average monthly cash profit	£360.33	(6.9%)	-£1.40
(Sold stocks profit + Dividends - Fees  / Months)
Performance/Injection	10.4%		+0%
Compound performance	52%		+0%

Cash is down by the cost of the JLP:Jubilee Metals shares and the TLOU:Tlou Energy open offer. The difference between cost and value worsened by £997 due to the OPTI:Optobiotix drop. Best news is JLP:Jubilee Metals getting into profit at last, and £372 potential profit is great given it was down by about 15% last week.

Still just above the injection line despite the drop

Only just above the trend line, but we've been the right side for 2 months now, so there is hope.

The SIPP looks like this after week 243

			Weekly Change
Cash	£1,485.74		-£916.14
Portfolio cost	£52,370.64		+£1,016.14
Portfolio sell value (bid price - commission)	£38,122.54	(-27.2%)	-£303.75
Potential profits	£75.98		+£32.91
Yr 5 Dividends	£28.67		+£0
Yr 5 Interest	£0.03		+£0
Yr 5 Profit from sales	£765.90		+£0
Yr 5 Average monthly cash profit	£84.53	(1.9%)	-£2.49
Total Dividends	£1,927.91		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£13,315.00		+£0
Average monthly cash profit	£261.93	(6.0%)	-£1.08
(Sold stocks profit + Dividends - Fees / Months)
Performance/Injection	9%		+0%
Compound performance	42%		+0%

My discipline to hold cash to buy back SBTX:SkinBioTherapeutics failed utterly as I've been watching PAY:Paypoint as the next potential addition to my magic formula portfolio. I decided the time was right, and so bought 178 shares at 561.34p costing £1,016.14 with commission and stamp duty. The timing was quite good as by the end of the week they were up 3% and £31 in profit. The cash dropped by £100 less than the purchase price as the tax rebate got paid in.

Despite being a good week, the difference between cost and value worsened by £303 thanks to the OPTI:Optibiotix drop. Potential profits rose by £32 and there are three shares in profit, with APAX:Apax Global Alpha up £37, FXPO:Ferrexpo losing ground but still £8 in profit, and PAY:Paypoint up £31.

There is still £1,485 left in cash for re-buying SBTX:SkinBioTherapeutics, and £2,000 pension transfer to add to it in a few weeks. Given I've used up my SBTX cash on JLP:Jubilee Metals in my ISA, I'm planning to put all £3,485 into SBTX when the price is right.

You can hardly see the dip

No sign of making the recovery stick - yet.

Here's the trading account after week 209

			Weekly Change
Cash	£732.67		+£516.62
Portfolio cost	£1,842.21		-£511.93
Portfolio sell value (bid price - commission)	£957.22	(-48.0%)	+£7.28
Potential profits	£0		-£21.84
Year 5 Dividends	£0		+£0
Year 5 Profit	£154.70		+£154.70
Yr 5 Average monthly cash profit	£670.35	(436.7%)	+£670.35
Dividends	£47.92		+£0
Profit from sales	£441.07		+£154.70
Average monthly cash profit	£10.14	(6.6%)	+£3.18
(Sold stocks profit + Dividends - Fees  / Months)

I sold my JLP:Jubilee Metals shares for 4.73p after buying at 3.4815p making £154.69 (29.5%) profit. Cash only went up by £516 as I pulled out £150 to reduce the injection to £2,000. That's £500 of the original injection that's been banked. The difference between cost and value improved by £7 as there were gains and losses in the other shares.

This is week 1 of year 5, so with the sale and projected performance over the next 12 months, the figure of £670 a month is crazy. That will settle down over the weeks, unless of course I manage to maintain £150 a week performance, which is highly unlikely. Long term performance improved to £10 a month so I'm finally starting to see a decent return.

What to buy next? Unfortunately SBTX:SkinBioTherapeutics has climbed back to 20p instead of dropping. I'm almost tempted to buy OPTI:Optibiotix, but vowed not to sell any so that's off the table. I need to see if anything has been clobbered recently that may recover. Looking at my existing portfolio there is one candidate. TLOU:Tlou Energy has just done an open offer and the share price has slumped to that figure. There could be potential for a short term recovery, and the announcment of resumed de-watering could see a spike. None of the rest of my existing portfolio look like a good candidate.

Cost and value have suddenly come very close together following the sale all going into cash and supporting the green line. When I buy again the red line will return to where it was, but green line will stay behind.

Very little change here as the sale and profit taking don't impact this chart. Only the difference between cost and value of actual shares matters here.

The virtual magic formula portfolio was down by 15.02% last week and is now down by 15.12% so very little change. There are now 7 shares in profit and the same three down by more than 50%. Maybe I should be checking those as potential trading shares?

How did we do with last weeks wishes?

As predicted we had another OPTI:Optibiotix Wellbiome announcement that didn't stir the market and didn't prevent the drop, so the SweetBiotix announcement is still awaited. That wish carries over. My wish for JLP:Jubilee Metals was to get to 5p. I didn't think that was going to happen so happy I sold at 4.7p and decided to keep my ISA holding longer term. The climb to 4.6p in my ISA was good, and 5p is still on my wish list for next week.

I wished one of APAX:Apax Global Alpha or POLR:Polar Capital Holdings getting into profit did come true, as APAX made it. My wish for this week is for POLR to join them. Still no sign of MTFB:Motif Bio announcing a reverse takeover. We have until Tuesday, so it's looking grim.

I feel bad wishing for SBTX to drop in price, but I want to buy back in, and it needs to get down to 16p. If I never get back in then I'll just have to rely on the OPTI:Optibiotix dividend. I guess that my other wish is I find a suitable share for the trading account.

Week 258 Review - Goodbye to SkinBioTherapeutics, or is it adieu?

This week was very flat. Hardly anything changed, but a 1p rise in OPTI:Optibiotix meant the difference between cost and value of the portfolios improved by £1,348. The deficit is now £34,496 and total portfolio value plus cash is £84,210.

The only big loser was SAE:Simec Atlantis Energy which dropped 5% after announcing it was only going ahead with half the capacity at Uskmouth. I'm surprised this caused a drop, because if I was managing the project I would have started out getting the one generator working before embarking on the second as it means revenue is coming in faster, and any teething troubles that might require changes will be addressed before starting the second phase, making that phase much smoother. The drop means these are 77% down and a long way from being in profit.

JLP:Jubilee Metals had a reasonable week. I think it would have been better if they didn't announce they were planning on buying more copper rich tailings in the near future, as everyone assumes there will be a placing to pay for it and so the superb trading figures only caused a 5% rise in my ISA and 7% in my trading account.

Share of the week is FXPO:Ferrexpo, which climbed 6% and returned to profit. It's nice to have some green in the SIPP.

Ooh look - a mysterious dip in cost - what could that be?

Heading in the right direction, but for how long?

Here's the ISA and share accounts

			Weekly Change
Cash	£1,723.26		+£1,482.20
Portfolio cost	£60,657.71		-£1,432.53
Portfolio sell value (bid price-commission)	£40,997.39	(-32.4%)	+£1,061.53
Potential profits	£0		+£0
Yr 5 Dividends	£0.85		+£0
Yr 5 Profit from sales	£35.20		+£49.68
Yr 5 Average monthly cash profit	-£0.45	(-0%)	+£4.40
Total Dividends	£1,343.15		+£0
Total Profit from sales	£20,426.61		+£49.68
Average monthly cash profit	£361.73	(7.2%)	-£0.57
(Sold stocks profit + Dividends - Fees  / Months)
Performance/Injection	10.4%		+0%
Compound performance	52%		+0%

Cash is up and cost down because I sold SBTX:SkinBioTherapeutics. Why did I sell for a measly £49 profit? I was fed up of resistance keep being hit at 20p as the traders manipulate the share. It's a self fulfilling prophecy, but it's been going on for ages and with my purchase being made at 19.5p I never quite got into profit before it dropped.

This time it hit 20.51p so I sold them quick, thinking I would both get the year 5 performance in the black and then be able to buy back on the inevitable drop. I can afford to take risks with these shares as I have a massive stake in OPTI:Optibiotix so I already own a big chunk of this company. It's about time I got a bit more mercenary instead of watching everyone else make profits from the volatility.

So far it's looking like the right thing to have done, as the bid price has dropped to 18.5p and I could buy back at 19.25p and increase my holding. I'm holding out until 16p though.

Although the sale put me in the black by £35 for year 5, I forgot there are still some ISA charges to take into account, and so my year 5 performance is still in the red by 45p a month. I still have 2 weeks of the year to go, so that will improve by a few pence, but I won't be able to sell anything more. The only impact on my long term performance was to make the drop slightly less than it would have been. An average of £361 a month for 5 years isn't bad though, but it's not enough to live on!

Back above the injection line

Bouncing off the trend line and managed to stay the right side.

Here's the SIPP after week 242

			Weekly Change
Cash	£2,401.88		+£2,353.80
Portfolio cost	£51,354.51		-£1,704.34
Portfolio sell value (bid price - commission)	£37,410.16	(-27.2%)	+£236.20
Potential profits	£43.07		-£377.20
Yr 5 Dividends	£28.67		+£0
Yr 5 Interest	£0.03		+£0
Yr 5 Profit from sales	£765.90		+£649.46
Yr 5 Average monthly cash profit	£87.02	(2.0%)	+£82.64
Total Dividends	£1,927.91		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£13,315.00		+£649.46
Average monthly cash profit	£263.01	(6.1%)	+£10.59
(Sold stocks profit + Dividends - Fees / Months)
Performance/Injection	9%		+0.4%
Compound performance	42%		+2%

I sold my SBTX:SkinBioTherapeutics shares in this account too, but did a lot better as I bought them for 14.654p and sold 7,500 for 20.63p making £424.30 (20.62%) profit and 4,049 for 20.51p making £225.16 (20.5%) profit. I split the sale as the exchange market size for SBTX is 7,500 and I wanted to ensure I could get an online quote. I cost me an extra £11.95 commission, but I got a good price for the first sale.

I've kept the cash as I want to re-invest in SBTX:SkinBioTherapeutics once it drops down to 16p. If it doesn't drop to that price, then I'll either buy more OPTI:Optibiotix with it or another magic formula share. I really want to increase my SBTX holding though, so hope I can stay disciplined and see through that plan. It would be a first!

The impact of the sale has been to dramatically improve my year 5 performance by £82 a month, but it's still a long way behind previous years. It hardly made any difference to the long term performance, improving by just £10 a month. I'm hoping that by increasing the number of dividend paying shares in my SIPP I'll be able to at least maintain this performance level without needing to sell as much. However, the magic formula system does rely on selling any shares that after holding for a year are no longer in the top 30 ranked companies. That gives FXPO:Ferrexpo to the end of May 2021 to re-rate enough for me to sell up. However, it it's still paying a great dividend, I might not sell.

It's nice when the cost comes down and the value goes up, although the value does include the cash.

Above the trend line, but I fear a long way to go before it flattens out.

The trading account looks like this after week 208 and indeed the end of year 4

			Weekly Change
Cash	£216.05		+£0
Portfolio cost	£2,354.14		+£0
Portfolio sell value (bid price - commission)	£1,461.87	(-37.9%)	+£51.03
Potential profits	£21.84		+£21.84
Year 4 Dividends	£13.20		+£0
Year 4 Profit	£350.66		+£0
Yr 4 Average monthly cash profit	£30.32	(15.5%)	-£0.60
Dividends	£47.92		+£0
Profit from sales	£286.37		+£0
Average monthly cash profit	£6.96	(3.6%)	-£0.04
(Sold stocks profit + Dividends - Fees  / Months)

Most shares were slightly up, and JLP:Jubilee Metals are in profit, but not enough for me to sell yet. I do think these ought to re-rate to around 5p from the current 3.8p but if it looks like that might take a long time I'll sell for a smaller profit.

Year 4 finished with an average monthly profit of £30 which is absolutely brilliant considering the unmitigated disaster of the first 3 years. It's just a real shame I have 4 moribund shares and am relying on recycling the same £500 in order to make any profit. I just haven't progressed to the point where I'm willing to take a big loss in order to free up the cash. If I'd have stopped out the loss much earlier then I would have been able to re-invest in something else, but I missed that opportunity. I just need to make sure I don't make the same mistake again.

Onwards and upwards

The trend line gets a little less flat, and it's in the right direction.

The virtual magic formula portfolio had a down week, going from 14.84% to 15.02% down. There are still only 5 companies in the black. ITV:ITV, CARD:Card Factory, and VTY:Vistry Group are all down by more than 50%. I'm surprised that PAY:Paypoint is down by 41%, so am very tempted to add this to my real magic formula holding, as they pay quarterly dividends. I may end up using some of my SBTX:SkinBioTherapeutics cash after all. So much for discipline! It would be a "loan" until my next pension transfer comes in, although the risk is I miss a good buying price.

As for my wishes for the week, we're still waiting on that magic SweetBiotix announcement from OPTI:Optibiotix, but I suspect we'll just get more Wellbiome announcements as all the partners dealing with Slimbiome take that on as well. Although those are all good news, they are unlikely to excite the market.

FXPO:Ferrexpo did get back in the black so that one came true. SBTX:SkinBioTherapeutics passed 20p allowing me to sell, so that was great. I'm not anticipating a sudden drop to 16p so doubt I'll be able to buy them back next week. JLP:Jubilee Metals getting to 5p is firmly on next week's list, and one of either APAX:Apax Global Alpha or POLR:Polar Capital Holdings getting back in the black, as they are only down by a little.

My biggest concern at the moment is MTFB:Motif Bio, who only have until 28th July to make a reverse takeover acquisition. It's not looking very promising! I really don't want it going down to the wire, so my number one wish for next week is an announcement a deal has been done.

Week 257 Review - Friday saved the week

It was looking like another miserable week right up to Friday afternoon, when a £2,700 loss became a £2,183 gain. Although that's not even clawed back last weeks losses, it's a whole lot better than I was expecting. The deficit between cost and value narrowed to £35,845 and total portfolio value is £81,657.

There was only one big loser this week, with IQE:IQE dropping 6% in my ISA. The drops were smaller in the other accounts, but the recent positive trend seems to have come to an abrupt halt. Even my ISA holding is 41% down, and that was meant to be the short term "quick win" bought at a bargain price for quick profit. The SIPP holding was bought in the peak of optimism and is 66% down.

APAX:Apax Global Alpha is one of my new magic formula shares, and rather typically had halted its post-Covid recovery the second I bought them. They increased 5% this week and so are worth more than I paid for them, but commission charges mean they are still £1.36 underwater. I'm hoping they will be green next week. The next dividend ex-date will be in early August with payment in mid-September.

CAML:Central Asia Metals had a good week, climbing 7%. As my 2nd largest holding that did wonders for my SIPP. They gave a very positive update, but frustratingly didn't mention when they will review the postponed dividend. Kazakhstan has re-imposed Covid lockdown after a recent spike, so I can see why the board remain cautious. These are still 16% down, and such a bargain I'm tempted to get some more.

FXPO:Ferrexpo is another one of my magic formula shares, and also climbed 7% this week. It means they are only 2% down now and another I hope will go into the green next week.

Share of the Week is SBTX:SkinBioTherapeutics which surged 10% in my ISA and 14% in my SIPP. Unfortunately I sold my trading account holding just before the surge, but more of that in the appropriate section. My SIPP holding is up 25% and I need to start thinking about whether I stick to my plan to take profits at 19.5p as it may happen next week. My ISA holding is still 7% down. If anything that's the one I ought to consider selling at a smaller profit just to clear the fact I bought them so expensive and hang fire for the next dip. Selling them never really feels like selling them as I still have such a big stake via OPTI:Optibiotix.

Always a relief to bounce off the injection line

Managed to prevent dipping below the trend line, but still following it down.

Here's the ISA and share portfolios

			Weekly Change
Cash	£241.06		-£3.75
Portfolio cost	£62,090.24		+£0
Portfolio sell value (bid price-commission)	£41,368.39	(-33.4%)	+£892.20
Potential profits	£0		+£0
Yr 5 Dividends	£0.85		+£0
Yr 5 Profit from sales	£-14.48		+£0
Yr 5 Average monthly cash profit	-£4.85	(-0.1%)	-£0.23
Total Dividends	£1,343.15		+£0
Total Profit from sales	£20,376.93		+£0
Average monthly cash profit	£362.30	(7.0%)	-£1.48
(Sold stocks profit + Dividends - Fees  / Months)
Performance/Injection	10.4%		-0.1%
Compound performance	52%		+0%

Cash dropped due to the monthly fee and I still have my £200 cash waiting on the TLOU:Tlou Energy open offer. Most of the rise was due to OPTI:Optibiotix climbing 1p, but given it was making a 3p loss until Friday lunchtime that was a good week. I only have 3 weeks until the end of year 5 and I'm still making a loss for the year. My best hope of getting into positive territory is selling SBTX:SkinBioTherapeutics for a small profit. 20.5p would do it, but given resistance is 20p I don't think it's going to happen.

Still below the injection line, but only just.

Boing!

The SIPP looks like this after week 241

			Weekly Change
Cash	£48.08		-£14.27
Portfolio cost	£53,058.85		+£0
Portfolio sell value (bid price - commission)	£38,878.30	(-26.7%)	+£1,346.67
Potential profits	£420.27		+£230.98
Yr 5 Dividends	£28.67		+£0
Yr 5 Interest	£0.03		+£0
Yr 5 Profit from sales	£116.44		+£0
Yr 5 Average monthly cash profit	£4.38	(0.1%)	-£2.06
Total Dividends	£1,927.91		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£12,665.54		+£0
Average monthly cash profit	£252.42	(5.7%)	-£1.31
(Sold stocks profit + Dividends - Fees / Months)
Performance/Injection	8.6%		-0.1%
Compound performance	40%		+0%

Cash dropped due to the monthly fees, and portfolio value increased by much more than the ISA thanks to the addition of CAML:Central Asia Metals and my magic formula shares. Potential profits are up by £230 thanks to SBTX:SkinBioTherapeutics and I'm sorely tempted to cash it in next week and wait for the inevitable drop to increase my holding.

As the cost goes up the value has been going down, so we're a long, long way from being back in the black.

Another save from dipping below the trend line.

The trading account looks like this after week 207

			Weekly Change
Cash	£216.05		+£0
Portfolio cost	£2,354.14		+£0.03
Portfolio sell value (bid price - commission)	£1,410.84	(-40.1%)	-£55.04
Potential profits	£0		-£30.72
Year 4 Dividends	£13.20		+£0
Year 4 Profit	£350.66		+£29.71
Yr 4 Average monthly cash profit	£30.92	(15.8%)	+£1.96
Dividends	£47.92		+£0
Profit from sales	£286.37		+£29.71
Average monthly cash profit	£7.00	(3.6%)	+£0.59
(Sold stocks profit + Dividends - Fees  / Months)

I thought JLP:Jubilee Metals were about to surge after the recent dip, and I thought SBTX:SkinBioTherapeutics was about to start slipping again. I was wrong on both counts.

I sold my holding in SBTX:SkinBioTherapeutics for a measly £29.71 (5.6%) profit but would have made £97 if I'd waited until Friday. Meanwhile the shares JLP:Jubilee Metals gave to Horizon for the recent tailings deal were all sold off and the share price dipped further, although recovered to 3.55p by the end of Friday. I bought 14,361 shares on Monday at 3.4815p costing £511.93. They are only losing commission now, so I'm still hopeful they will allow a relatively quick profit, especially if we get a trading statement.

Next week is the final week of year 4 for this account, so whatever happens I'm going to end up with over £30 a month (15.8%) average profit for the year. That's exactly the sort of thing I hoped this account would generate, so I'm very happy. It's a shame I've had to do that based on just £500 of my stake. It makes me realise how much I could have made if the early decisions weren't so dreadful.

Long term performance is now £7 a month over 4 years, which is 3.6%. Well below my usual 10% target, but given I was loss making for the first 3 years it's a lot better.

Slowly but steadily moving towards at least the injection line

That's it - the trend line is pointing upwards for the first time in forever! Granted it's a hell of a long way below zero, but at least moving in the right direction.

Last week the virtual magic formula portfolio was down 15.45% and this week it's only down 14.84%. If next week's pension transfer takes me above £2,200 I'll need to do some number crunching to find out which two new shares to buy. It's really tempting just to get another £2,000 worth of CAML:Central Asia Metals though. The mind boggles at why those are still so low.

Looking at last week's wishes, we still haven't had SweetBiotix news for OPTI:Optibiotix. CAML:Central Asia Metals had a chance to mention the dividend but didn't, so I'm scrubbing that off my wish list until autumn. FXPO:Ferrexpo is not back in the black, but is getting close so that wish will stay. SBTX:SkinBioTherapeutics got close to 19.5p but I'd already sold up my trading shares. I may still sell my SIPP if they get there this week. JLP:Jubilee Metals did drop a little allowing me to buy, so a fast rise is back on my wish list because of the trading account, so I need a trading update and to hit 5p.

Week 256 Review - Another slide downwards, but more bargain Optibiotix in the bag

It's been another rubbish week, with another £2,810 knocked off the portfolio value. No massive crashes, but OPTI:Optibiotix drifting another 2p accounted for most of the drop.It's very demoralising, as the dip drip decline has been going on for 6 weeks now, aside for one brief increase. The gap between cost and value has widened to £38,029 and total portfolio and cash is worth £79,967.

JLP:Jubilee Metals dropped 9%, which makes me very relieved I sold my trading shares. Now it's at the level where I want to buy hem back again, so early next week I will aim to take a small profit from SBTX:SkinBioTherapeutics and buy these back.

SAE:Simec Atlantis Energy is still on a bit of a run, climbing 5%. They are still 68% down, but things are looking reasonably hopefull.

Share of the Week is MMX:Minds + Machines which climbed 6%. After going nowhere for ages, I'm wondering if maybe a dividend announcement is on the way? These are still 23% down but could soon make that up if a positive trading statement is issued.

Ooh dear, the orange line is moving up to meet the green one!

Only just above the trend line now. It could be worse I suppose.

The ISA and share portfolios look like this

			Weekly Change
Cash	£244.81		+£230.18
Portfolio cost	£62,090.24		+£2,019.82
Portfolio sell value (bid price-commission)	£40,476.19	(-34.8%)	-£1,897.70
Potential profits	£0		+£0
Yr 5 Dividends	£0.85		+£0
Yr 5 Profit from sales	£-14.48		+£0
Yr 5 Average monthly cash profit	-£4.62	(-0.1%)	+£0.09
Total Dividends	£1,343.15		+£0
Total Profit from sales	£20,376.93		+£0
Average monthly cash profit	£363.78	(7.0%)	-£1.43
(Sold stocks profit + Dividends - Fees  / Months)
Performance/Injection	10.5%		-0.6%
Compound performance	52%		-2%

Quite a lot going on here. Cash has gone up by £230 because I added some to cover the TLOU:Tlou Energy open offer. I've applied for 8,809 shares which is above my allocation, but if I get them it will take my holding to 40,000 shares. Given my average purchase price is 8.66p and the open offer is for 2.2p, I should bring my average down quite a lot. I could buy them for the same price on the open market, but would have to pay commission.

The cost went up by £2,019 because I did what I always do when OPTI:Optibiotix drops. I get upset and buy some more while they're cheap, then I feel much better. I've saved a fortune during lockdown and have paid off my visa bill completely, so I figured I could stand a £2,000 loan over 12 months. I used it to buy 3,810 shares at 52.7p costing 2,019.82.

That brings my total OPTI:Optibiotix holding to 115,471 at an average price of 64.14p costing £74,487.91. They are currently losing £17,942.97 which is beyond frustrating, but it doesn't matter. The story is still good. There was a huge announcement this week of a deal with a company that supplies pharmacies and doctors who will be putting their own already respected brand on LP-LDL. I still don't understand how the market can't see that deal after deal is building revenues slowly but steadily to a point where they just take off. When that point hits, the panic to buy these will be pandemonium. That's when the years of frustration will evaporate.

A bad week, with the portfolio value losing £1,897 and the increased injection meant a drop in both the performance compared to injection and compound performance. In summary, we're not doing very well at the moment.

The injection line has overtaken the value line and we're back having less than we put in. Bugger!

Amazingly we're still above the trend line, which is a surprise.

The SIPP looks like this after week 240

			Weekly Change
Cash	£62.35		+£28.67
Portfolio cost	£53,058.85		+£0
Portfolio sell value (bid price - commission)	£37,531.63	(-29.3%)	-£907.54
Potential profits	£189.29		+£0
Yr 5 Dividends	£28.67		+£28.67
Yr 5 Interest	£0.03		+£0
Yr 5 Profit from sales	£116.44		+£0
Yr 5 Average monthly cash profit	£6.44	(0.1%)	+£3.79
Total Dividends	£1,927.91		+£28.67
Total Interest	£0.20		+£0
Total Profit from sales	£12,665.54		+£0
Average monthly cash profit	£253.73	(5.7%)	-£0.54
(Sold stocks profit + Dividends - Fees / Months)
Performance/Injection	8.7%		+0%
Compound performance	40%		+0%

I had a dividend from FXPO:Ferrexpo! £28.67 was a lot less than I was expecting thanks to Swiss withholding tax, which actually means the dividend yield isn't anywhere near as good as suggested in my ranking spreadsheet. It's still better than nothing and has boosted my average performance for year 5 by £3.79 a month, and reduced my long term monthly dip to just 54p.

Aside from that the value dropped by £907. After this week I'm just happy to have lost less than £1,000.

One great bit of news is that there will be more than £2,200 in my SIPP when my July contribution is paid, so I can do a transfer request and should be able to get another 2 magic formula shares in late August, unless I crack and buy more OPTI:Optibiotix! I'm contemplating trying out AJ Bell so I don't risk having all my shares with one broker.

Still a reasonable gap to the injection line, but it's a hell of a long way up to the cost line.

Once again we do enough to stay above the trend line.

The trading account looks like this after week 206

			Weekly Change
Cash	£186.37		+£0
Portfolio cost	£2,354.11		+£0
Portfolio sell value (bid price - commission)	£1,465.85	(-37.7%)	-£4.90
Potential profits	£30.72		+£0
Year 4 Dividends	£13.20		+£0
Year 4 Profit	£320.95		+£0
Yr 4 Average monthly cash profit	£28.96	(14.8%)	-£0.59
Dividends	£47.92		+£0
Profit from sales	£256.66		+£0
Average monthly cash profit	£6.41	(3.3%)	-£0.03
(Sold stocks profit + Dividends - Fees  / Months)

Pretty flat this week. I only have 2 weeks left of year 4, so want to give the performance a wee boost before then. The potential profits for SBTX:SkinBioTherapeutics are tiny, but there's a risk that will be stuck in this range for a while, whereas JLP:Jubilee Metals are much more likely to go on a run from the recent dip. I want to get back in there now, so will sell as soon as possible next week. the profits this month are enough to pay my phone bill, so things are looking much better. £6.41 a month long term profit is a bit rubbish though.

Slow and steady climb. Not at all like a trading account should look.

That trend line is a whisker off being flat. We're well above it and I do believe by next week it might have tipped the other way.

The virtual magic formula account is down 15.45% as opposed to 14.6% last week, so it's been a bad week all round. There are only 4 shares in profit so it's looking grim. It's handy as a barometer of the wider market though, and puts this week's losses in perspective.

Looking at last week's wishes, we still haven't had SweetBiotix news for OPTI:Optibiotix, but we did have another great deal which caused a drop in share price. CAML:Central Asia Metals still haven't re-instated the dividend, but I'm confident they will. FXPO:Ferrexpo is not back in the black, in fact it's down 9%, but only 6% if you include the dividend.

SBTX:SkinBioTherapeutics is nowhere near 19.5p and I doubt will be for a while now. JLP:Jubilee Metals has done the opposite of my wish and dropped to 3.4p instead of climbing to 4.5p. The only thing that did come true last week was being able to apply for the TLOU:Tlou Energy open offer, so not a complete failure.

In that case I'll put all my wishes back in play, with the caveat that ideally SBTX:SkinBioTherapeutics will climb a little on Monday and JLP:Jubilee Metals continue to drop until I can get them back in my trading account.

That's it - time for a pizza and bottle of Malbec. I might do a Jack Reacher I and II back-to-back this evening.